Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort.
about
Self management for patients with chronic obstructive pulmonary diseaseExtrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary diseaseDiagnosing COPD: advances in training and practice - a systematic reviewNon-pharmacological treatments for COPDMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseRespiratory syncytial virus infections enhance cigarette smoke induced COPD in micePharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewComputerised Analysis of Telemonitored Respiratory Sounds for Predicting Acute Exacerbations of COPD.Self-treatment of acute exacerbations of chronic obstructive pulmonary disease requires more than symptom recognition - a qualitative study of COPD patients' perspectives on self-treatmentUndiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study.Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCTDomiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot studyDaily activity during stability and exacerbation of chronic obstructive pulmonary diseaseHow do COPD patients respond to exacerbations?Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.Detecting exacerbations using the Clinical COPD QuestionnairePredictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.Heuristic evaluation of online COPD respiratory therapy and education video resource center.The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbationsAssociation between lung function and exacerbation frequency in patients with COPD.Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD)Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study.Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion.Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study.Clinical diaries in COPD: compliance and utility in predicting acute exacerbations.The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.History of pneumonia is a strong risk factor for chronic obstructive pulmonary disease (COPD) exacerbation in South Korea: the Epidemiologic review and Prospective Observation of COPD and Health in Korea (EPOCH) study.The role of bronchodilator treatment in the prevention of exacerbations of COPD.Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial"Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.Exacerbation rate, health status and mortality in COPD--a review of potential interventionsComplexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.
P2860
Q24197903-92E727AC-D804-4D84-86A4-A371676BDD21Q26745663-DEAF8885-9C43-421B-BF78-C9E716D24082Q26751313-852AEDAF-6907-4BA8-B24B-EA80063310EFQ26751407-13EB5372-17AC-43F1-AD11-E8F114EA1492Q27000043-1457CA9C-C1BD-4256-85DF-58AB9CAA892EQ27317947-E50BD7D6-2F86-48A7-820A-3D3A03C6D09CQ28070274-64B0AA18-B22E-43F7-A0A2-ADDC4B36CA9FQ30398378-0C660C7E-B579-449B-8C8B-1312F853E2F9Q30836396-513EEB7A-F11E-4A87-8938-F2BE1623AE41Q31042243-74DD1D72-FE16-44C4-AD9A-128B2CF40FC8Q33440006-D410D591-95A7-42C6-AAD5-AF7BFFAC2369Q33521100-E3C87463-904E-4AD3-B847-1149234A59A0Q33723544-254D2362-3411-424E-B9D0-B598F3E199F0Q33755164-91E1273D-C7A1-4511-99B9-64B9E76102CDQ33997722-65DA43EC-D9A5-4248-9F9D-3F809D8160ADQ34092876-A1DFA140-F7E7-43B9-AB1C-566D3486139DQ34174389-977D8C33-5331-4997-BA3D-E3C7577E4F17Q34287563-2D3D2E25-CBA8-415D-AF07-306F014713BBQ34300659-2490E450-5460-4918-A4F3-56709E6D1493Q34425489-8F78D0FA-E395-4EDC-93A4-FB9277A8EFB3Q34432556-325C22E2-398A-4B6E-AD82-B18768BDEF3DQ34547587-C41606FB-407A-4C3F-97C1-974410B35294Q34612842-FE43D385-F9AA-4181-9392-DA78F121C306Q34840845-19F5A896-C40E-4645-BA6D-E6078CB885C9Q35138038-9362D91E-8727-4266-82CA-7965364E06D8Q35225129-1D0027D7-1F9D-4045-B3E0-9C88093BF642Q35671708-E90B22F3-2F32-468C-9044-67D1A5C1979BQ35804617-0130EBBE-78C3-4267-AA58-D43854D01BF6Q35862715-3A26112A-0F59-4837-8B02-C4122EF76689Q36108515-C7E9A3EC-E36A-487E-9727-D2226D7AEC1CQ36288980-DB73B0AE-1619-401B-B87D-96A4372D4A5EQ36394339-825234B0-4D51-4CC7-A142-37ADB09070CBQ36437545-9AD5C48E-830A-4C2F-AE0A-97FC6721EFC5Q36438669-423BBB1D-31AA-4F1E-9726-C77FB0758B47Q36444197-C7D8C10F-8B90-4502-B378-52E58F8D1506Q36444402-8CCFAC3A-32FF-410F-A01D-CA655BB8A579Q36557724-1179117C-BE6A-473E-8AB1-4036C8CEF7A4Q36908069-CE19B48B-4264-4E8F-A9D7-89F38BDB27C7Q37236165-EBCD1EFE-901B-45CC-BBBE-E651A980191BQ37274731-EE9F3BB6-E121-4469-9E3E-B2E4BD6A893C
P2860
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@en
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@nl
type
label
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@en
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@nl
prefLabel
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@en
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@nl
P2860
P1476
Underreporting exacerbation of ...... ease in a longitudinal cohort.
@en
P2093
Jean Bourbeau
Pierre Ernst
P2860
P304
P356
10.1164/RCCM.200708-1290OC
P407
P577
2007-11-29T00:00:00Z